AO-VISION Symposium 2026 – replay available
Interested in learning how ultrahigh-resolution retinal imaging can benefit medical research and therapeutic development in inherited retinal diseases as well as non-ophthalmic systemic diseases? Curious about AI-powered adaptive optics retinal biomarkers for clinical trials? Then the replay of the AO-VISION Symposium 2026 is for you.
Contact us via the form below to request access to the replay video — we’ll be glad to point you to the sessions most relevant to your work and answer any questions.
On July 2, 2026, 90 clinicians, researchers, and AI developers gathered at Erasmus MC in Rotterdam and online for the AO-VISION Symposium — a shared vision for AO retinal imaging. Twelve speakers presented their research using the rtx1 AO retinal camera, followed by two panel discussions on cellular and microvascular biomarkers, covering conditions ranging from inherited retinal dystrophies (retinitis pigmentosa, Usher syndrome) to macular hole, glaucoma, diabetes, arterial hypertension, and multiple sclerosis.
Thank you to all speakers, panelists, chairs, moderators, poster presenters, and participating centers for such a stimulating day.
Organizers: Danilo Andrade de Jesus (Erasmus MC & Rotterdam Eye Hospital) and Marine Durand (Imagine Eyes).
AO-VISION Symposium 2026 – PROGRAM
Opening remarks — Nicole Naus, EMC Rotterdam
Session 1 — Cellular Biomarkers: Retina
Chair: Ingerborg van den Born, Rotterdam Eye Hospital
- AO-Vision project: imaging protocol & biomarkers for IRDs — Danilo Andrade de Jesus, Erasmus MC & Rotterdam Eye Hospital
- Case report: PRPH2 — Colin Park, Ghent University Hospital
- AO imaging in USH2A-RP: deep phenotyping — Mechteld van Olden, Radboud UMC
- Macular hole and monitoring after surgery — Vincent Bourgonje, on behalf of Saskia van Romunde, Rotterdam Eye Hospital
Session 2 — Cellular Biomarkers: Retina & Systemic Conditions
Chair: Alberta Thiadens, Erasmus MC
- Krill’s disease, acute RPE epitheliitis — Pam Heutinck, Erasmus MC Rotterdam
- AO in multiple sclerosis — Lajos Csincsik, Belfast Ophthalmic Reading Centre, Queen’s University Belfast
- Glucose tolerance & cone photoreceptor density (Maastricht Study) — Huixin Tang, Maastricht University
- EYS-associated RP: 2-year natural history with AO (KEYS study) — Kiyoko Gocho, Kobe Eye Center & 15-20 National Eye Hospital
Panel 1 — Cellular biomarkers: AO strategies & open innovation for AI
Danilo Andrade de Jesus, Kiyoko Gocho, Lajos Csincsik
Session 3 — Microvascular Biomarkers Chair: Vincent Bourgonje, Rotterdam Eye Hospital
- High precision reitnal vascular metrics for digital twins — Michel Paques, 15-20 National Eye Hospital
- Wall-to-lumen ratio estimation in AO images — Radim Kolar, Brno University of Technology
- Remodelling of retinal arteries in POAG with RTX1 AO camera — Zbigniew Wawrzyniak, Warsaw University of Technology
- Retinal artery evolution in arterial hypertension (4-yr follow-up) — Anna Zaleska-Żmijewska, Medical University of Warsaw
Panel 2 — Microvascular assessments: AO applications & AI analytics
Anna Zaleska-Żmijewska, Radim Kolar, Zbigniew Wawrzyniak
Closing remarks — Future collaborations, consensus groups for AO retinal imaging
Request replay access
